Home ›
Trademark Categories ›
Science & Technology Services ›
2013 ›
PR ›
PRIME ONCOLOGY
Trademark search for:
PRIME ONCOLOGY
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2013-07-11 — Application filed
2013-09-12 — Sn assigned for sect 66a appl from ib
2013-09-17 — Application filed
2013-09-21 — Application filed
2013-10-24 — Assigned to examiner
2013-11-01 — Final disposition recorded
2013-11-02 — Office action issued
2013-11-07 — Office action issued
2013-11-07 — Office action issued
2013-11-23 — Office action issued
2014-05-07 — Attorney/dom.rep.revoked and/or appointed
2014-05-07 — Application abandoned
2014-05-07 — Teas revoke/app/change addr of atty/dom rep received
2014-05-08 — Application abandoned
2014-05-08 — Application abandoned
2015-02-18 — Notification of possible opposition sent to ib
2015-02-18 — Notification of possible opposition created, to be sent to ib
2015-03-06 — Notification of possible opposition - processed by ib
2015-05-08 — Final disposition recorded
2015-05-08 — Final disposition recorded
2015-05-31 — Change of name/address rec'd from ib
2015-06-12 — Final disposition recorded
2020-01-30 — New representative at ib received
2023-07-10 — Final status recorded
2024-02-04 — Death of international registration
2024-02-05 — Notification of effect of cancellation of intl reg e-mailed
Correspondent
Nicholas D. Wells Wells IP Law 299 South Main Street, Suite 1300 Salt Lake City, UT 84111 UNITED STATES
Filing Details
Filing Date:
2013-07-11
Status Date:
2023-07-10
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.